Mohammad Haddadi: New Insights on Chronic Histiocytic Intervillositis Outcomes
Mohammad Haddadi, Medical Doctor at Aflatoon Clinic, shared a post on LinkedIn about a paper published in International Journal of Gynecological Pathology:
“Proud to share our latest publication in the International Journal of Gynecological Pathology, ‘Placental Chronic Histiocytic Intervillositis: Pregnancy Outcomes and Complications – A Systematic Review and Meta-Analysis’.
Chronic histiocytic intervillositis (CHI) is a rare but serious placental inflammatory condition with profound implications for pregnancy outcomes. In this systematic review and meta-analysis, we synthesized evidence from 12 studies encompassing 568 pregnancies to better quantify maternal and neonatal risks associated with idiopathic CHI.
Key findings:
- 40% pooled frequency of intrauterine growth restriction (IUGR)
- 55% live birth rate
- 20% intrauterine fetal death (IUFD)
- Findings remained consistent in sensitivity analyses restricted to low-risk studies
Our results highlight the substantial burden of adverse outcomes associated with CHI and reinforce the need for early recognition, standardized diagnostic criteria, and targeted management strategies in affected pregnancies.
Grateful to work with an excellent team of collaborators. Looking forward to seeing how these findings contribute to improved placental pathology awareness and maternal–fetal care.
Link.”
Title: Placental Chronic Histiocytic Intervillositis: Pregnancy Outcomes and Complications, a Systematic Review and Meta-Analysis
Authors: Elena Ghotbi, Zeinab Mansouri, Alireza Azarboo, Nasim Eshraghi, Marjan Ghaemi, Mohammad Haddadi, Zahra Panahi, Sedigheh Hantoushzade

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 28, 2026, 16:59Unlocking the Potential of Menstrual Blood in Health Testing – Global Women’s Health Innovation Conclave
-
Jan 28, 2026, 16:57New Insights on Oocyte Yield in Endometriosis and PCOM – RBMO
-
Jan 28, 2026, 16:51Transform Your Expertise with ESHRE eCampus Learning – ESHRE
-
Jan 28, 2026, 16:46Accelerate Your Growth at the AP3G National Meeting – ASRM
-
Jan 28, 2026, 16:43Debojit Saha: Unraveling Chromosomal Errors in Aging Human Eggs
-
Jan 28, 2026, 16:38Silvia Vannuccini: RBMO Highlights Key Insights on Adenomyosis Awareness
-
Jan 28, 2026, 16:32Maximilian Attwood: Challenging Medical Misogyny in Endometriosis Research
-
Jan 28, 2026, 16:29Ioakeim Sapantzoglou: New Perspectives on Fetal Growth Restriction and Genetic Testing
-
Jan 28, 2026, 16:26Enhancing Pre-Eclampsia Prediction with Doppler Indices – ISUOG
